帕金森病患者和抑郁症患者的单胺损失和功能连接性改变
Bao-Lei Xu1,2, Xiu-Lin Liu1, Olivier Barret3
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
CNS neuroscience & therapeutics
|December 26, 2025
概括
帕金森病中的抑郁症涉及单胺系统缺陷和改变的奖励电路连接. 这项研究发现,抑郁症帕金森病患者的缺陷更大,连接性更强,这表明了治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 与帕金森病 (PD) 相关的抑郁病理生理学和神经基础尚不清楚.
- 单氨基系统调节失调和中临界-基底质奖励回路异常与PD相关的抑郁症有关.
研究的目的:
- 在患有抑郁症的PD患者中调查单氨基缺陷和条状体-半边缘电路变化.
- 为了将这些神经生物学发现与PD中的抑郁症严重程度相关联.
主要方法:
- 同时使用18F-烯基二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二
- 使用18F-FP-DTBZPET标准化吸收值比率在状体-介质膜子区域的量化单氨基缺陷.
- 通过基于voxel和volume-of-interest的方法,分析了条状体-半边形电路中的功能连接性变化.
主要成果:
- 与非抑郁患者相比,患有抑郁症的PD患者在前背部/腹部门和腹核中表现出更大的单氨基缺陷.
- 抑郁症的严重程度与前腹膜和核中的单氨基缺陷有负相关性.
- 患有抑郁症的PD患者在条纹体-介质膜回路内表现出增加的功能连接性.
结论:
- 帕金森病中的抑郁症的特征是,在条体-中共路径中同时出现单氨基缺陷和超连接性.
- 条纹体-介质膜回路代表了在帕金森病中管理抑郁症的潜在治疗点.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.2K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.1K
相关概念视频
Parkinson's Disease: Treatment
933
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
933
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564
